Yasushi Nagata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yasushi Nagata has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Masahiro Hiraoka
Kyoto University
5 shared publicationsKenji Takayama
Kyoto University
4 shared publicationsMichihide Mitsumori
Kyoto University, Graduate School of Medicine
4 shared publicationsTakashi Mizowaki
Kyoto University
4 shared publicationsNorio Araki
3 shared publicationsShinsuke Yano
Kyoto University, Graduate School of Medicine
3 shared publications
Latest Publications
- 22 October 2007
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (5) , 356-362
Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors
The purpose of this study was to evaluate the characteristics of mass-like consolidation of the lung on computed tomography (CT) after stereotactic body radiation therapy (SBRT) retrospectively.
- 22 October 2007
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (5) , 356-362
Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors
The purpose of this study was to evaluate the characteristics of mass-like consolidation of the lung on computed tomography (CT) after stereotactic body radiation therapy (SBRT) retrospectively.
- 25 February 2007
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (1) , 3-7
Current status of stereotactic body radiotherapy for lung cancer
Stereotactic radiotherapy (SRT) for extracranial tumors has been recently performed to treat lung and liver cancers, and has subsequently been named stereotactic body radiotherapy (SBRT). The advantages of hypofractionated radiotherapy for treating lung tumors are a shortened treatment course that requires fewer trips to the clinic than a conventional program, and the adoption of a smaller irradiated volume allowed by greater setup precision. This treatment is possible because the lung and liver are considered parallel organs at risk. The preliminary clinical results, mostly reported on lung cancer, have been very promising, including a local control rate of more than 90%, and a relatively low complication rate. The final results of a few clinical trials are awaited. SBRT may be useful for the treatment of stage I lung tumors.
- 25 February 2007
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (1) , 3-7
Current status of stereotactic body radiotherapy for lung cancer
Stereotactic radiotherapy (SRT) for extracranial tumors has been recently performed to treat lung and liver cancers, and has subsequently been named stereotactic body radiotherapy (SBRT). The advantages of hypofractionated radiotherapy for treating lung tumors are a shortened treatment course that requires fewer trips to the clinic than a conventional program, and the adoption of a smaller irradiated volume allowed by greater setup precision. This treatment is possible because the lung and liver are considered parallel organs at risk. The preliminary clinical results, mostly reported on lung cancer, have been very promising, including a local control rate of more than 90%, and a relatively low complication rate. The final results of a few clinical trials are awaited. SBRT may be useful for the treatment of stage I lung tumors.
- Top Cited Papers
- 1 December 2005
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 63 (5) , 1427-1431
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
- 1 December 2005
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 63 (5) , 1427-1431
Top Cited PapersClinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
- 1 March 2000
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 11 (3) , 313-319
Neoadjuvant Chemotherapy by Transcatheter Arterial Infusion Method for Uterine Cervical Cancer
- 1 March 2000
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 11 (3) , 313-319
Neoadjuvant Chemotherapy by Transcatheter Arterial Infusion Method for Uterine Cervical Cancer